Organovo Holdings Inc. is a biotechnology company that designs and creates functional human tissues using 3D bioprinting technology. The company’s breakthrough method allows for the creation of organs and tissues for drug discovery and transplantation, addressing the critical need for more effective and efficient medical research and treatment options.
